CD19CAR T cell products of defined composition can be reproducibly generated from heavily treated leukemic pediatric patients

Explore related products in the following collection:

Poster Abstracts - C717

ePosters - C717

Related Products

Thumbnail for Site-specific conjugation of novel flourophores and tags to accelerate immunotherapy discovery and development

Site-specific conjugation of novel flourophores and tags to accelerate immunotherapy discovery and development

Thumbnail for Promotion of immunogenicity using epigenetic modulation and immune checkpoint inhibition in mouse models of breast cancer

Promotion of immunogenicity using epigenetic modulation and immune checkpoint inhibition in mouse models of breast cancer

Thumbnail for In Vitro Anticancer Activity of Polysaccharide and Protein Fractions from Pithecellobium jiringa

In Vitro Anticancer Activity of Polysaccharide and Protein Fractions from Pithecellobium jiringa

Thumbnail for Beyond Immune Checkpoint: First-in-Class antibody targeting soluble NKG2D ligand sMIC for cancer immunotherapy

Beyond Immune Checkpoint: First-in-Class antibody targeting soluble NKG2D ligand sMIC for cancer immunotherapy

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.